GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (OTCPK:IDGXF) » Definitions » PB Ratio

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) PB Ratio : 2.14 (As of May. 21, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Integrated Diagnostics Holdings PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-21), Integrated Diagnostics Holdings's share price is $0.308. Integrated Diagnostics Holdings's Book Value per Share for the quarter that ended in Jun. 2023 was $0.14. Hence, Integrated Diagnostics Holdings's PB Ratio of today is 2.14.

The historical rank and industry rank for Integrated Diagnostics Holdings's PB Ratio or its related term are showing as below:

IDGXF' s PB Ratio Range Over the Past 10 Years
Min: 2.23   Med: 4.06   Max: 6.68
Current: 2.23

During the past 12 years, Integrated Diagnostics Holdings's highest PB Ratio was 6.68. The lowest was 2.23. And the median was 4.06.

IDGXF's PB Ratio is ranked worse than
51.71% of 205 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.19 vs IDGXF: 2.23

During the past 12 months, Integrated Diagnostics Holdings's average Book Value Per Share Growth Rate was -1.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -15.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -8.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -9.20% per year.

During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Integrated Diagnostics Holdings was 9.10% per year. The lowest was -24.00% per year. And the median was -14.95% per year.

Back to Basics: PB Ratio


Integrated Diagnostics Holdings PB Ratio Historical Data

The historical data trend for Integrated Diagnostics Holdings's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrated Diagnostics Holdings PB Ratio Chart

Integrated Diagnostics Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.24 3.90 5.47 4.16 2.34

Integrated Diagnostics Holdings Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.44 4.16 3.41 3.76 2.34

Competitive Comparison of Integrated Diagnostics Holdings's PB Ratio

For the Diagnostics & Research subindustry, Integrated Diagnostics Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integrated Diagnostics Holdings's PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Integrated Diagnostics Holdings's PB Ratio distribution charts can be found below:

* The bar in red indicates where Integrated Diagnostics Holdings's PB Ratio falls into.



Integrated Diagnostics Holdings PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Integrated Diagnostics Holdings's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2023)
=0.308/0.144
=2.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Integrated Diagnostics Holdings  (OTCPK:IDGXF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Integrated Diagnostics Holdings PB Ratio Related Terms

Thank you for viewing the detailed overview of Integrated Diagnostics Holdings's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Business Description

Traded in Other Exchanges
Address
12 Castle Street, Saint Helier, JEY, JE2 3RT
Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider. It is a fully integrated diagnostics service provider operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segment- Contract Segment and Walk-in Segment. It derives majority of its revenue from services offered in Egypt.

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Headlines

From GuruFocus

Equity Portfolio as a Savings Account

By Steven CHEN 09-24-2021